Fielmann Group Reports Strong Financial Growth in FY2024

The Fielmann Group announced its preliminary financial results for FY2024, revealing a 15% increase in consolidated sales to €2.3 billion. The growth was fueled by strong organic expansion in Europe and the consolidation of US acquisitions. Adjusted EBITDA rose 23%, aligning with market expectations set mid-year, with notable margin improvements in both European and US markets.

Despite economic challenges, Fielmann maintained organic growth across central Europe with Germany, Switzerland, and Austria showing significant sales increases. The US division reported sales growth reaching €200 million, bolstered by strategic acquisitions and a strong performance in primary eyecare services.

Strong demand was observed across categories, with prescription eyewear and hearing aids showing impressive growth rates. As a result, the Fielmann Group is optimistic about maintaining its market position amidst ongoing macroeconomic challenges and plans to propose a dividend increase at the upcoming shareholder meeting.